​

Enhabit (EHAB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Enhabit Revenue Highlights

Latest Revenue (Y)

$1.03B

Latest Revenue (Q)

$266.10M

Main Segment (Y)

Home Health Segment

Enhabit Revenue by Period

Enhabit Revenue by Year

DateRevenueChange
2024-12-31$1.03B-1.10%
2023-12-31$1.05B-3.40%
2022-12-31$1.08B-2.12%
2021-12-31$1.11B2.63%
2020-12-31$1.08B-1.26%
2019-12-31$1.09B-

Enhabit generated $1.03B in revenue during NA 2024, up -1.10% compared to the previous quarter, and up 94.76% compared to the same period a year ago.

Enhabit Revenue by Quarter

DateRevenueChange
2025-06-30$266.10M2.39%
2025-03-31$259.90M0.66%
2024-12-31$258.20M1.81%
2024-09-30$253.60M-2.69%
2024-06-30$260.60M-0.69%
2024-03-31$262.40M0.69%
2023-12-31$260.60M0.89%
2023-09-30$258.30M-1.52%
2023-06-30$262.30M-1.06%
2023-03-31$265.10M-3.64%
2022-12-31$275.10M3.54%
2022-09-30$265.70M-0.86%
2022-06-30$268.00M-2.30%
2022-03-31$274.30M-0.65%
2021-12-31$276.10M0.80%
2021-09-30$273.90M-4.26%
2021-06-30$286.10M5.77%
2021-03-31$270.50M-

Enhabit generated $266.10M in revenue during Q2 2025, up 2.39% compared to the previous quarter, and up 101.41% compared to the same period a year ago.

Enhabit Revenue Breakdown

Enhabit Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22
Home Health Segment$824.80M$850.10M$877.10M

Enhabit's latest annual revenue breakdown by segment (product or service), as of Dec 24: Home Health Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22
Home Health Segment$205.90M$200.60M$410.60M$201.00M$213.20M$209.60M$210.90M$213.80M$215.80M$215.70M$216.30M$220.20M

Enhabit's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Home Health Segment (100.00%).

Enhabit Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CYHCommunity Health Systems$12.63B$3.09B
AGLAgilon Health$6.06B$1.39B
SYSo-Young$1.50B$318.28M
EHABEnhabit$1.03B$266.10M
TOIOncology Institute$393.41M$104.41M
AMRNAmarin$204.59M$46.62M
CATXPerspective Therapeutics$1.43M-
RAPTRAPT Therapeutics--
AURAAura Biosciences--
CCRNCross Country Healthcare-$293.41M
DBVTDBV--

EHAB Revenue FAQ

What is Enhabit’s yearly revenue?

Enhabit's yearly revenue for 2024 was $1.03B, representing a decrease of -1.10% compared to 2023. The company's yearly revenue for 2023 was $1.05B, representing a decrease of -3.40% compared to 2022. EHAB's yearly revenue for 2022 was $1.08B, representing a decrease of -2.12% compared to 2021.

What is Enhabit’s quarterly revenue?

Enhabit's quarterly revenue for Q2 2025 was $266.1M, a 2.39% increase from the previous quarter (Q1 2025), and a 2.11% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $259.9M, a 0.66% increase from the previous quarter (Q4 2024), and a -0.95% decrease year-over-year (Q1 2024). EHAB's quarterly revenue for Q4 2024 was $258.2M, a 1.81% increase from the previous quarter (Q3 2024), and a -0.92% decrease year-over-year (Q4 2023).

What is Enhabit’s revenue growth rate?

Enhabit's revenue growth rate for the last 3 years (2022-2024) was -4.46%, and for the last 5 years (2020-2024) was -4.03%.

What are Enhabit’s revenue streams?

Enhabit's revenue streams in c 24 are Home Health Segment

What is Enhabit’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Enhabit was Home Health Segment. This segment made a revenue of $824.8M, representing 100.00% of the company's total revenue.